Several cytotoxic agents have been reported to cause lung damage, the commonest being bleomycin, busulphan, and methotrexate.' We wish to report the occurrence of interstitial pneumonitis in a patient with a cadaveric renal and pancreatic allograft receiving prednisolone and azathioprine as immunosuppressive treatment.
A 38 year old woman was admitted on 1 January 1981 with a five day history of night sweats and rigors associated with fever. She had been an insulin dependent diabetic from the age of 10 years and commenced chronic intermittent haemodialysis in January 1980 because of end stage diabetic nephropathy. She had developed diabetic retinopathy 10 years previously. This had been treated by vitrectomy on the right and photocoagulation in both eyes.
In April 1980 she received a pancreatic and renal allograft and was immunosuppressed with cyclosporin A. She required insulin for six hours postoperatively. She was readmitted on 8 August 1980 with a serum creatinine concentration of 452 gmolI (5-1 mg/100 ml), which had risen from a level of 173 ,umol/l (2-0 mg/100 ml) recorded on 13 July. A renal biopsy specimen showed appearances of severe rejection and she was treated with methylprednisolone (1 g daily intravenously for three days). Her renal function continued to deteriorate (serum creatinine 840 ,umolI (9-5 mg/100 ml) and a further biopsy specimen on 2 September again showed appearances of rejection. Her treatment was changed to prednisolone (75 mg/day) and azathioprine (1-5 mg/kg = 75 mg/day). Her renal function improved (serum creatinine 216 ,umol/I (2-4 mg/100 ml) and the dose of corticosteroid was accordingly reduced. She required insulin as a result of deterioration in glucose tolerance secondary to corticosteroid treatment. At the time of her admission at the beginning of 1981 she was receiving prednisolone 17-5 mg/day and azathioprine 50 mg/day (reduced because of leucopenia).
On admission on 1 January 1981 she had extensive perioral herpes simplex and a swinging fever, rising at its height to 40°C. Investigations showed a serum creatinine concentration of 215 ,umol/l (2-4 mg/100 ml), haemoglobin 9.9 g/dl, white cell count 2-3 x 109/l (eosinophils 0-1 x 109/l), and platelets 272 x 109/l. The chest radiograph was normal; blood, urine, and sputum cultures were negative. Paired sera for rising antibody titres to influenza virus A and B, cytomegalovirus, adenovirus, Coxiella burnetii, Mycoplasma pneumoniae, and Chlamydia psittaci showed no evidence of infection with these agents. Despite negative bacterial cultures the patient was started on flucloxacillin and amikacin. After six days' treatment there was no improvement and she was treated with acyclovir (225 mg three times a day) for three days. Her pyrexia continued and she became progressively dyspnoeic with the development of basal crepitations. Successive chest radiographs showed the gradual appearance of bilateral diffuse shadowing of nodular type. The arterial oxygen tension was 9 9 kPa (74 mm Hg); lung function studies showed a restrictive defect with appreciable decrease in carbon monoxide transfer factor (table). On 20 January a drill biopsy of her left lung was performed. Histological examination showed mild interstitial infiltration, mainly with lymphocytes and plasma cells, and some early alveolar wall fibrosis. The alveoli were patchily but extensively Carmichael, Hamilton, Evans, Stovin, Calne
In reports published in English azathioprine induced interstitial pneumonitis has been reported in two patients. Rubin et a12 report the development of an acute restrictive pulmonary disease in a 20 year old man with ulcerative colitis after treatment with azathioprine (100 mg/day) for six weeks. He complained of a dry cough, rapidly increasing exertional dyspnoea, and fever. The chest radiograph showed bilateral basal shadowing and respiratory function tests showed severe reduction in vital capacity, FEVy, and carbon monoxide gas transfer. Two days after discontinuation of azathioprine his chest radiograph and results of respiratory function tests were normal. Lung biopsy was not performed. Weisenberger3 describes an acute interstitial pneumonitis in a 24 year old woman with rapidly progressive renal failure secondary to membranoproliferative glomerulonephritis who was treated with azathioprine (150 mg/day) for two years. She developed fever, dry cough, and shortness of breath. Serial chest radiographs showed progressive pulmonary infiltrates and there was reduction in arterial oxygen tension. Open lung biopsy showed an acute interstitial pneumonitis; hyperplasia of type 2 pneumocytes was prominent. Within a week of her stopping azathioprine the patient's symptoms had improved and within two weeks they had resolved and the chest radiograph was normal.
Azathioprine is metabolised to 6-mercaptopurine, which has also been incriminated in interstitial pneumonitis; Sostman et a14 report the development of interstitial pneumonitis, confirmed by lung biopsy, in a two year old boy with leukaemia after three days' treatment with 6-mercaptopurine. This is the first reported case of interstitial pneumonitis in a renal transplant recipient despite the extensive use of azathioprine in these patients. Drug induced interstitial pneumonitis can be misdiagnosed as an opportunistic infection. Cyclosporin A provides an alternative immunosuppressive agent in patients who develop this complication after transplantation. 
